he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies...treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic).

may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful.